2C (psychedelics)

Family of phenethylamine psychedelics

2C (2C-x) is a general name for the family of psychedelic phenethylamines containing methoxy groups on the 2 and 5 positions of a benzene ring.[1] Most of these compounds also carry lipophilic substituents at the 4 position, usually resulting in more potent and more metabolically stable and longer acting compounds.[2] Most of the currently known 2C compounds were first synthesized by Alexander Shulgin in the 1970s and 1980s and published in his book PiHKAL (Phenethylamines i Have Known And Loved). Shulgin also coined the term 2C, being an acronym for the 2 carbon atoms between the benzene ring and the amino group.[3]

General structure of a 2C compound
Nomenclature R3 R4 2D Structure CAS number
2C-B H Br 66142-81-2
2C-Bn H CH2C6H5
2C-Bu H CH2CH2CH2CH3
2C-C H Cl 88441-14-9
2C-C-3 [4] Cl Cl
2C-CN H C≡N 88441-07-0
2C-D H CH3 24333-19-5
2C-E H CH2CH3 71539-34-9
2C-EF H CH2CH2F 1222814-77-8
2C-F H F 207740-15-6
2C-G CH3 CH3 207740-18-9
2C-G-1 CH2
2C-G-2 (CH2)2
2C-G-3 (CH2)3 207740-19-0
2C-G-4 (CH2)4 952006-59-6
2C-G-5 (CH2)5 207740-20-3
2C-G-6 (CH2)6
2C-G-N (CH)4 207740-21-4
2C-H H H 3600-86-0
2C-I H I 69587-11-7
2C-iP H CH(CH3)2 1498978-47-4
2C-TBU H C(CH3)3
2C-CP H C3H5 2888537-46-8
2C-CPE H C5H9
2C-N H NO2 261789-00-8
2C-NH2 H NH2 168699-66-9
2C-PYR H Pyrrolidine
2C-PIP H Piperidine
2C-O H OCH3 15394-83-9
2C-O-4 H OCH(CH3)2 952006-65-4
2C-MOM [5] H CH2OCH3
2C-P H CH2CH2CH3 207740-22-5
2C-Ph H C6H5
2C-Se H Se CH3 1189246-68-1
2C-T H SCH3 61638-09-3
2C-T-2 H SCH2CH3 207740-24-7
2C-T-3[6] H SCH2C(=CH2)CH3 648957-40-8
2C-T-4 H SCH(CH3)2 207740-25-8
2C-T-5[6]
2C-T-6[6]
2C-T-7 H S(CH2)2CH3 207740-26-9
2C-T-8 H SCH2CH(CH2)2 207740-27-0
2C-T-9[6] 207740-28-1
2C-T-10[6]
2C-T-11[6]
2C-T-12[6]
2C-T-13 H S(CH2)2OCH3 207740-30-5
2C-T-14[6]
2C-T-15 H SCH(CH2)2
2C-T-16[7] H SCH2CH=CH2 648957-42-0
2C-T-17 H SCH(CH3)CH2CH3 207740-32-7
2C-T-18[6]
2C-T-19 H SCH2CH2CH2CH3
2C-T-21 H S(CH2)2F 207740-33-8
2C-T-21.5[6] 648957-46-4
2C-T-22[6] 648957-48-6
2C-T-23[6]
2C-T-24[6]
2C-T-25[6]
2C-T-27[6] 648957-52-2
2C-T-28[6] 648957-54-4
2C-T-30[6]
2C-T-31[6]
2C-T-32[6]
2C-T-33[6]
2C-T-DFM H SCF2H
CYB210010[8] H SCF3
2C-T-DFP H SCH2CH2CF2H
2C-T-PARGY H SCH2C≡CH
2C-DFM [9]: 770  H CHF2
2C-TFM H CF3 159277-08-4
2C-TFE H CH2CF3
2C-PFE H CF2CF3
2C-PFS H SF5
2C-YN H C≡CH 752982-24-4
2C-V H CH=CH2
2C-AL[10] H CH2CH=CH2

Legality

Canada

As of October 12, 2016, the 2C-x family of substituted phenethylamines is a controlled substance (Schedule III) in Canada.[11]

See also

References

  1. ^ Alexander Shulgin, Tania Manning and Paul F Daley. The Shulgin Index. Volume 1. Psychedelic Phenethylamines and Related Compounds. Transform Press, 2011. ISBN 978-0-9630096-3-0
  2. ^ Daniel Trachsel, David Lehmann and Christoph Enzensperger. Phenethylamine Von der Struktur zur Funktion, pp 762-810. Nachtschatten Verlag AG, 2013. ISBN 978-3-03788-700-4
  3. ^ Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628.
  4. ^ Takahashi M, Nagashima M, Suzuki J, Seto T, Yasuda I, Yoshida T. Creation and application of psychoactive designer drugs data library using liquid chromatography with photodiode array spectrophotometry detector and gas chromatography–mass spectrometry. Talanta, 15 Feb 2009, 77(4): 1245–1272. doi:10.1016/j.talanta.2008.07.062
  5. ^ Leth-Petersen S, Petersen IN, Jensen AA, Bundgaard C, Bæk M, Kehler J, Kristensen JL. 5-HT2A/5-HT2C receptor pharmacology and intrinsic clearance of N-benzylphenethylamines modified at the primary site of metabolism. ACS Chem. Neurosci., 16 Nov 2016, 7 (11), 1614–1619. doi:10.1021/acschemneuro.6b00265
  6. ^ a b c d e f g h i j k l m n o p q r s t "Shulgin's Sulfur Symphony – Part I". countyourculture. 15 January 2011. Archived from the original on 19 September 2019. Retrieved 22 October 2017.
  7. ^ Daniel Trachsel (2003). "Synthesis of novel (phenylalkyl)amines for the investigation of structure-activity relationships. Part 2. 4-Thio-substituted [2-(2,5-dimethoxyphenyl)ethyl]amines (=2,5-dimethoxybenzeneethanamines)". Helvetica Chimica Acta. 86 (7): 2610–2619. doi:10.1002/hlca.200390210.
  8. ^ Varty GB, Canal CE, Mueller TA, Hartsel JA, Tyagi R, Avery K, Morgan ME, Reichelt AC, Pathare P, Stang E, Palfreyman MG, Nivorozhkin A. Synthesis and Structure-Activity Relationships of 2,5-Dimethoxy-4-Substituted Phenethylamines and the Discovery of CYB210010: A Potent, Orally Bioavailable and Long-Acting Serotonin 5-HT2 Receptor Agonist. J Med Chem. 2024 Apr 25;67(8):6144-6188. doi:10.1021/acs.jmedchem.3c01961 PMID 38593423
  9. ^ Daniel Trachsel; David Lehmann & Christoph Enzensperger (2013). Phenethylamine: Von der Struktur zur Funktion. Nachtschatten Verlag AG. ISBN 978-3-03788-700-4.
  10. ^ Kruegel AC. Phenalkylamines and Methods of Treating Mood Disorders. Patent WO 2022/006186
  11. ^ "Regulations Amending the Food and Drug Regulations (Part J — 2C-phenethylamines)". Canada Gazette. April 15, 2016. Retrieved August 28, 2016.
  • v
  • t
  • e
2C family of psychedelics
  • v
  • t
  • e
Psychedelics
(5-HT2A
agonists)
Benzofurans
Lyserg‐
amides
Phenethyl‐
amines
2C-x
25x-NBx
25x-NB
25x-NB3OMe
  • 25B-NB3OMe
  • 25C-NB3OMe
  • 25D-NB3OMe
  • 25E-NB3OMe
  • 25H-NB3OMe
  • 25I-NB3OMe
  • 25N-NB3OMe
  • 25P-NB3OMe
  • 25T2-NB3OMe
  • 25T4-NB3OMe
  • 25T7-NB3OMe
  • 25TFM-NB3OMe
25x-NB4OMe
  • 25B-NB4OMe
  • 25C-NB4OMe
  • 25D-NB4OMe
  • 25E-NB4OMe
  • 25H-NB4OMe
  • 25I-NB4OMe
  • 25N-NB4OMe
  • 25P-NB4OMe
  • 25T2-NB4OMe
  • 25T4-NB4OMe
  • 25T7-NB4OMe
  • 25TFM-NB4OMe
25x-NBF
25x-NBMD
  • 25B-NBMD
  • 25C-NBMD
  • 25D-NBMD
  • 25E-NBMD
  • 25F-NBMD
  • 25H-NBMD
  • 25I-NBMD
  • 25P-NBMD
  • 25T2-NBMD
  • 25T7-NBMD
  • 25TFM-NBMD
25x-NBOH
25x-NBOMe
Atypical structures
25x-NMx
  • 25B-NMe7BF
  • 25B-NMe7BT
  • 25B-NMe7Bim
  • 25B-NMe7Box
  • 25B-NMe7DHBF
  • 25B-NMe7Ind
  • 25B-NMe7Indz
  • 25B-NMePyr
  • 25I-NMe7DHBF
  • 25I-NMeFur
  • 25I-NMeTHF
  • 25I-NMeTh
N-(2C)-fentanyl
  • N-(2C-B) fentanyl
  • N-(2C-C) fentanyl
  • N-(2C-D) fentanyl
  • N-(2C-E) fentanyl
  • N-(2C-G) fentanyl
  • N-(2C-H) fentanyl
  • N-(2C-I) fentanyl
  • N-(2C-IP) fentanyl
  • N-(2C-N) fentanyl
  • N-(2C-P) fentanyl
  • N-(2C-T) fentanyl
  • N-(2C-T-2) fentanyl
  • N-(2C-T-4) fentanyl
  • N-(2C-T-7) fentanyl
  • N-(2C-TFM) fentanyl
3C-x
4C-x
DOx
HOT-x
MDxx
Mescaline (subst.)
TMAs
  • TMA
  • TMA-2
  • TMA-3
  • TMA-4
  • TMA-5
  • TMA-6
Others
Piperazines
Tryptamines
alpha-alkyltryptamines
x-DALT
x-DET
x-DiPT
x-DMT
x-DPT
Ibogaine-related
x-MET
x-MiPT
Others
Others
Dissociatives
(NMDAR
antagonists)
Arylcyclo‐
hexylamines
Ketamine-related
PCP-related
Others
Adamantanes
Diarylethylamines
Morphinans
Others
Deliriants
(mAChR
antagonists)
Others
Cannabinoids
(CB1 agonists)
Natural
Synthetic
AM-x
CP x
HU-x
JWH-x
Misc. designer cannabinoids
D2 agonists
GABAA
enhancers
Inhalants
(Mixed MOA)
κOR agonists
Oneirogens
Others
  • v
  • t
  • e
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
  • See also: Receptor/signaling modulators
  • Adrenergics
  • Dopaminergics
  • Melatonergics
  • Monoamine reuptake inhibitors and releasing agents
  • Monoamine metabolism modulators
  • Monoamine neurotoxins
  • v
  • t
  • e
TAAR1
Agonists
Endogenous
Synthetic and natural
Neutral antagonists
Inverse agonists
TAAR2
Agonists
 
Neutral antagonists
  •  
TAAR5
Agonists
Neutral antagonists
  •  
Inverse agonists
References for all endogenous human TAAR1 ligands are provided at List of trace amines


References for synthetic TAAR1 agonists can be found at TAAR1 or in the associated compound articles. For TAAR2 and TAAR5 agonists and inverse agonists, see TAAR for references.


See also: Receptor/signaling modulators
  • v
  • t
  • e
Phenethylamines


Stimulants: Phenylethanolamine

Amphetamines
Phentermines
Cathinones
Phenylisobutylamines
Phenylalkylpyrrolidines
Catecholamines
(and close relatives)
Miscellaneous